MMJ Observer
Tag Archives: NASDAQ:CRON

Medipharm Labs Corp (OTCMKTS:MEDIF) has entered a supply accord with Cronos Group Inc (NASDAQ:CRON) to supply high quality cannabis under the private label. The deal is worth $30 million and valid for 18 months. The contract could be extended...

By Jaime Williams on May 24th, 2019

Cronos Group Inc (NASDAQ:CRON) steps up efforts to offer cannabis experience to the users in the form of vapor. The company opened an R&D Center – Cronos Device Labs in Israel to develop new vaporizer devices and offer enhanced cannabis...

By David Rees on May 15th, 2019

Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) announced the financial results for the second quarter of 2018 amid positive energy all across the company. As per Mike Gorenstein, CEO of Cronons Group, the company has focused on setting the stage...

By Jaime Williams on Sep 5th, 2018